Trials / Unknown
UnknownNCT00972829
Tolerability and Lipid Lowering Effect of Weekly/Biweekly Crestor in Statin Intolerant Patients Treated With Zetia
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Bronx VA Medical Center · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Recently, research studies have shown that patients who have had trouble taking statins every day, are able to take statins if they take them only once or twice a week. The investigators are doing a research study which involves switching people who are taking ezetimibe to the statin Crestor once or twice a week and to see how ell Crestor lowers cholesterol and if it is tolerated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rosuvastatin | Rosuvastatin 10 or 20 milligrams once or twice a week |
| DRUG | Ezetimibe | Ezetimibe 5 or 10 milligrams |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-12-01
- Completion
- 2011-03-01
- First posted
- 2009-09-09
- Last updated
- 2009-09-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00972829. Inclusion in this directory is not an endorsement.